The table below shows UroGen Pharma Ltd.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$109.79M
$90.40M
$82.71M
$64.36M
$48.04M
$11.80M
Cost of revenue
$12.45M
$8.88M
$9.36M
$7.65M
$5.16M
$1.01M
Gross profit
$97.34M
$81.52M
$73.35M
$56.70M
$42.88M
$10.79M
R&D
$67.11M
$57.15M
$45.61M
$52.91M
$47.64M
$47.31M
URGN annual revenue (10-K history)
UroGen Pharma Ltd. reported annual revenue of $109.79M for fiscal year 2025. That is up 21.4% from $90.40M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $17.53M (FY 2016) to $109.79M. Figures come from the company's audited annual reports as filed with the SEC.